Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1997-02-21
1999-03-30
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 3140
Patent
active
058890424
ABSTRACT:
Compounds of this formula ##STR1## are useful for treating or preventing Alzheimer's disease, premenstrual syndrome, peri-menopausal syndrome, a deficiency of thrombomodulin, uterine fibrosis, excessive myeloproxidase activity, excessive thrombin, autoimmune disease, reperfusion damage of ischemic myocardium and insufficient testosterone.
REFERENCES:
patent: 4418068 (1983-11-01), Jones
patent: 4859585 (1989-08-01), Sonnenschein
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5254594 (1993-10-01), Kazuaki et al.
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5389670 (1995-02-01), Fontana
patent: 5391557 (1995-02-01), Cullinan et al.
patent: 5393763 (1995-02-01), Black et al.
patent: 5418252 (1995-05-01), Williams
patent: 5434166 (1995-07-01), Glasebrook
patent: 5439923 (1995-08-01), Cullinan
patent: 5439931 (1995-08-01), Sales
patent: 5441966 (1995-08-01), Dodge
patent: 5441986 (1995-08-01), Thompson
patent: 5446053 (1995-08-01), Koehane
patent: 5447941 (1995-09-01), Zuckerman
patent: 5451589 (1995-09-01), Dodge
patent: 5451590 (1995-09-01), Dodge
patent: 5455275 (1995-10-01), Fontana
patent: 5457113 (1995-10-01), Cullinan
patent: 5457116 (1995-10-01), Black et al.
patent: 5457117 (1995-10-01), Black et al.
patent: 5461064 (1995-10-01), Cullinan
patent: 5461065 (1995-10-01), Black et al.
patent: 5462937 (1995-10-01), Cullinan et al.
patent: 5462949 (1995-10-01), Jones et al.
patent: 5462950 (1995-10-01), Fontana
patent: 5464845 (1995-11-01), Black et al.
patent: 5470883 (1995-11-01), Stromberg
patent: 5550164 (1996-08-01), Fontana
Klaus, S. et al. "In Vivo and in Vitro Antiestrogenic Action of 3-Hydroxytamoxifen, Tamoxifen and 4-Hydroxytamoxifen," Eur. J. Clin. Oncol., vol. 21, No. 8, pp. 985-990, 1985.
Eppenberger, U. et al. "Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen," Am. J. Clin. Oncol (CCT) 14, Suppl. 2, pp. S5-S14, 1991.
MacLean David B.
Thompson David D.
Butterfield Garth
Ginsburg Paul H.
Goldberg Jerome D.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Method of treating diseases and conditions with estrogen agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating diseases and conditions with estrogen agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating diseases and conditions with estrogen agonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1215547